11
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T12401 | Pemigatinib | INCB054828 | FGFR |
Pemigatinib (INCB054828) is an orally active, selective inhibitor of FGFR(IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively). | |||
T3878 | Raddeanin A | NSC382873,Anemodeanin A,Raddeanin R3 | Apoptosis , HDAC |
Raddeanin A (NSC-382873) has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity. | |||
TN4591 | Murralongin | Others | |
Murralongin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100. | |||
TN4564 | Micromelin | Others | |
Micromelin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100. | |||
T70143 | Derazantinib dihydrochloride | ||
Derazantinib is a multi-kinase inhibitor with pan-FGFR activity which has shown preliminary therapeutic activity against FGFR2 fusion-positive intrahepatic cholangiocarcinoma (iCCA). Derazantinib dihydrochloride is a sa... | |||
TN4570 | Minumicrolin | Others | |
Minumicrolin is a plant growth inhibitor against the 2nd leaf sheath elongation of rice seedlings. Murrangatin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100, it might be valuable anti-tumor-promotin... | |||
T72932 | Triphen diol | ||
Triphen Diol, a phenol diol derivative, exhibits potent anticancer properties against pancreatic cancer and cholangiocarcinoma, efficiently inducing pancreatic cell apoptosis via both caspase-mediated and caspase-indepen... | |||
TN4592 | Murrangatin | IL Receptor , TNF , COX , Prostaglandin Receptor | |
Murrangatin may be a valuable anti-tumor-promoting agent, it can significantly inhibit Epstein-Barr virus early antigen (EBV-EA) activation, and preserve the high viability of Raji cells, it also exhibits cytotoxicity ag... | |||
T71002 | Infigratinib acetate | ||
Infigratinib acetate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities. | |||
T71004 | Infigratinib monohydrate | ||
Infigratinib monohydrate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities. | |||
T71003 | Infigratinib mesylate | ||
Infigratinib mesylate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities. |